MedPath

Aplisol

APLISOL (Tuberculin Purified Protein Derivative, Diluted [Stabilized Solution])

Approved
Approval ID

33ad349a-2969-4591-8c67-4d2a422a5ffb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 9, 2015

Manufacturers
FDA

TYA Pharmaceuticals

DUNS: 938389038

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tuberculin Purified Protein Derivative

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64725-0104
Application NumberBLA103782
Product Classification
M
Marketing Category
C73585
G
Generic Name
Tuberculin Purified Protein Derivative
Product Specifications
Route of AdministrationINTRADERMAL
Effective DateJuly 9, 2015
FDA Product Classification

INGREDIENTS (3)

Polysorbate 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
PhenolInactive
Code: 339NCG44TV
Classification: IACT
Tuberculin Purified Protein DerivativeActive
Quantity: 5 [iU] in 0.1 mL
Code: I7L8FKN87J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Aplisol - FDA Drug Approval Details